Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Compassionate Use of Hyperbaric Oxygen Therapy in the Treatment of COVID-19

NCT04386265 is registered in ClinicalTrials.gov with SerenaGroup, Inc. as lead sponsor.

NCT NCT04386265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04386265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Compassionate Use of Hyperbaric Oxygen Therapy in the Treatment of COVID-19
Lead sponsor
SerenaGroup, Inc.
Phase
Observational
Overall status
Unknown status
Start date
April 15, 2020
Completion date
May 11, 2022
Enrollment
100 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19